The goal of the study was to show that the colon lining had decreased levels of inflammatory markers. Although this was accomplished in this very small and short study, it remains unclear whether this has any importance in the complex pathways that lead to colonic polyps and ultimately, malignancies.
Look at how the headline – which starts the story – and the final sentence – conflict:
Americans are overwhelmed by a tsunami of health care news every day. Why was it vital that they receive this extremely preliminary information now? Can the flood of health care news – including from such tiny, early studies – simply confuse and turn off readers? We think so.
News decision-makers may say “Our readers have an unsatiable appetite for health news.” But where is the evidence that they want this kind of medical minutiae?
Reporting on results with intermediate endpoints such as were measured in the colonic biopsies may have nothing to do with ultimate health effects.
The story says that a month’s supply of ginger supplements typically runs about $10 – $30.
What does a decrease in inflammation level of 28% mean?
No context is given for the scope of this effect.
Barely satisfactory.
The story only says that previous animal research showed ginger “isn’t potentially toxic to the stomach like aspirin.”
What about in people?
The story states that the National Library of Medicine that ginger is “likely safe…although some people may develop side effects.
Yes, there were caveats, such as:
But our grade is unsatisfactory because the validity of the research isn’t questioned. How valid were the inflammation level measurements taken in the study?
What does a 28% decline in inflammation level mean? 28% of what? From what to what? What percentage is significant? We don’t even know whether these levels of inflammation (recall that the volunteers were healthy) are linked in any way to colon cancer development.
There is no evidence given that the kind of inflammation measured in study participants’ intestines is at all related to colon cancer.
Yet the headline reads: “Ginger Supplements Might Ease Inflammation Linked to Colon Cancer”
Is all stomach inflammation so linked?
Readers may think that inflammation itself is worrisome, when in fact inflammatory markers are always present to varying degrees.
One independent source was quoted.
No context was given about any other research in the field of the inflammation – colon cancer link.
Is this the only research in the field?
The relevant comparison may be the relative reduction in colorectal cancer risk (or inflammatory markers) with aspirin, the most common anti-inflammatory product most people are exposed to.
The story says ginger is found in supplements and in many foods. The availability of ginger supplements is implied elsewhere in the story.
The story at least gives this context:
“Previous research in animals has suggested that ginger can reduce inflammation but isn’t potentially toxic to the stomach like aspirin, Zick noted. And scientists have linked chronic inflammation in the gut to colon cancer, suggesting that easing this inflammation could reduce the risk of the disease.”
There’s no evidence that the story relied solely on a news release.
Systematic, Criteria-Driven
We’ve written about the hype of liquid biopsies for years (see link in comment below). And now this…. https://www.statnews.com/2022/01/12/medicare-shouldnt-cover-liquid-biopsies-early-cancer-detection/
Case counts still matter. “(There) are stories that may not be told adequately if only hospitalizations and deaths are emphasized.” @garyschwitzer interviewed by @dbauder of @AP. https://apnews.com/article/omicron-changing-news-outlets-covid-data-da9272f7c4c8a109c3bfb56bed9e9c76
My friend Gary @garyschwitzer wrote to his city council representative in a Minnesota town about a Viva Las Vegas event scheduled for January.
The response he got seems to perfectly capture where we are now.
https://www.healthnewsreview.org/2021/12/2021-ends-with-covid-craziness-in-sports-and-politics/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like